United Kingdom · Question · Written question
UIN 53385
Tixagevimab/cilgavimab
Original
Introduced
21 September 2022
Last action
11 October 2022 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
11 October 2022
Summary
To ask the Secretary of State for Health and Social Care, what the decision-making process was ahead of the decision not to procure Evusheld including what (a) discussions took place and (b) evidence was used to inform the decision; and for what reason th
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
21 September 2022
Written question
To ask the Secretary of State for Health and Social Care, what the decision-making process was ahead of the decision not to procure Evusheld including what (a) discussions took place and (b) evidence was used to inform the decision; and for what reason th
Source: Commons
11 October 2022
Answer
The Government has decided not to procure Evusheld for prevention through emergency routes at this time. This is a decision based on independent clinical advice by the multi-agency RAPID C-19 and a national expert policy working group. These groups consid...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2022-09-21/53385
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1507445
- uk · wq-1507445 · source updated 11 October 2022